小鼠骨桥蛋白的原核表达及多克隆抗体的制备与鉴定

doi:10.16431/j.cnki.1671-7236.2015.05.005

摘要/Abstract

摘要： 为探索骨桥蛋白(OPN)调控骨代谢及与肿瘤的关系,本试验利用DNAMAN与Mega 5.02软件分析OPN蛋白系统进化关系;采用RT-PCR与分子克隆方法制备OPN蛋白表达载体;利用SDS-PAGE电泳切胶纯化、尿素浓度梯度复性获得OPN蛋白,免疫小鼠制备OPN蛋白多克隆抗体;采用ELISA法检测抗体滴度,Western blotting检测抗血清特异性。OPN序列的同源性比对分析发现,在不同进化层次动物中均存在Arg-Gly-Asp(RGD)短肽重复序列;OPN序列系统进化分析显示,OPN在动物间具有明显的进化趋势;提取小鼠肝脏RNA,OPN重组载体双酶切、DNA测序鉴定结果及蛋白表达、纯化条带大小均与预测一致;ELISA法确认OPN抗血清滴度达1:1 600;Western blotting证实抗血清具有很好的特异性。结果表明本试验对OPN序列进行了遗传进化分析,成功克隆、表达、纯化及复性OPN蛋白,并制备、鉴定了小鼠多克隆抗体。

关键词: OPN蛋白; RT-PCR; 多克隆抗体; ELISA; Western blotting

Abstract: In order to explore the function of osteopontin (OPN) regulated bone metabolism and the relationship between OPN and tumor, DNAMAN and Mega 5.02 softwares were used to analyze phylogenetic relationships of OPN protein, the OPN expression vector was prepared by RT-PCR and molecular clone; OPN was purified by SDS-PAGE gel slices, renatured by urea concentration gradient, and immunized mice to prepare the polyclonal antibody; The antibody titer and specificity were detected by ELISA and Western blotting, respectively.The homology comparison result of OPN sequence showed that it existed short repeat sequenc Arg-Gly-Asp (RGD) in different animals with evolution levels.Phylogenetic tree of OPN sequence showed that OPN had obvious evolution trend among animals.RNA was extracted, OPN recombinant vector had been digested and sequenced to confirm the correct construction, and strip lengths of OPN expression and purification were agreed with the prediction.The OPN antiserum titer was 1:1 600 detected by ELISA, and Western blotting proved that the antiserum had good specificity.We had successfully analyzed genetic evolution relationship of OPN sequence, gotten OPN expression vector, purified and renatured OPN, and prepared and identified the polyclonal antibody against OPN.

Key words: OPN protein; RT-PCR; polyclonal antibody; ELISA; Western blotting

中图分类号:

Q786

刘祥, 陈春琳, 王杨科, 俱雄, 吴三桥, 张涛. 小鼠骨桥蛋白的原核表达及多克隆抗体的制备与鉴定[J]. , 2015, 42(5): 1069-1075.

LIU Xiang, CHEN Chun-lin, WANG Yang-ke, JU Xiong, WU San-qiao, ZHANG Tao. Prokaryotic Expression,Polyclonal Antibody Preparation and Identification of Mouse Osteopontin Protein[J]. , 2015, 42(5): 1069-1075.

参考文献

[1] Kariya Y, Kanno M, Matsumoto-Morita K, et al.Osteopontin O-glycosylation contributes to its phosphorylation and cell-adhesion properties[J]. Biochem J, 2014, 463(1):93-102.
[2] Sivakumar S, Niranjali Devaraj S.Tertiary structure prediction and identification of druggable pocket in the cancer biomarker——Osteopontin-c[J].J Diabetes Metab Disord, 2014, 13(1):1-14.
[3] Yokosaki Y, Tanaka K, Higashikawa F, et al.Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha beta1 to osteopontin[J].Matrix Biol, 2005, 24(6):418-427.
[4] Hunter G K.Role of osteopontin in modulation of hydroxyapatite formation[J].Calcif Tissue Int, 2013, 93(4):348-354.
[5] Meng H, Wang Z, Wang W, et al.Effect of osteopontin in regulating bone marrow mesenchymal stem cell treatment of skin wounds in diabetic mice[J].Diabetes Metab Res Rev, 2014, 30(6):457-466.
[6] 茅文斌, 邵增务.骨桥蛋白与骨质疏松症研究进展[J].中国骨质疏松, 2007, 13(3):204-207.
[7] Zurick K M, Qin C, Bernards M T.Mineralization induction effects of osteopontin, bone sialoprotein, and dentin phosphoprotein on a biomimetic collagen substrate[J].J Biomed Mater Res A, 2013, 101(6):1571-1581.
[8] Lund S A, Wilson C L, Raines E W, et al.Osteopontin mediates macrophage chemotaxis via α4 and α9 integrins and survival via the α4 integrin[J].J Cell Biochem, 2013, 114(5):1194-1202.
[9] 黄隽, 苏榕.膜联蛋白A2和骨桥蛋白在乳腺癌组织的表达及其与乳腺癌生物学行为的关系[J].中华实验外科杂志, 2013, 30(12):2688-2690.
[10] Sheng X J, Zhou D M, Liu Q, et al.BRMS1 inhibits expression of NF-kappaB subunit p65, uPA and OPN in ovarian cancer cells[J].Eur J Gynaecol Oncol, 2014, 35(3):236-242.
[11] Nagoshi S.Osteopontin:Versatile modulator of liver diseases[J].Hepatol Res, 2014, 44(1):22-30.
[12] 丁凌, 郑树, 曹江.大肠癌及其肝转移组织骨桥蛋白mRNA的表达[J].中华医学杂志, 2002, 82(14):970-973.
[13] 杨普, 古学萍, 张中冕, 等.骨桥蛋白在胃癌患者血清中的表达及其对肿瘤转移的作用[J].中华实验外科杂志, 2014, 31(7):1570-1572.
[14] Wu X L, Lin K J, Bai A P, et al.Osteopontin knockdown suppresses the growth and angiogenesis of colon cancer cells[J]. World J Gastroenterol, 2014, 20(30):10440-10448.
[15] Bandopadhyay M, Bulbule A, Butti R, et al.Osteopontin as a therapeutic target for cancer[J].Expert Opin Ther Targets, 2014, 18(8):883-895.
[16] Liu X, She X T, Zhu Q F, et al.Heterogeneous interactome between Litopenaeus vannamei plasma proteins and Vibrio parahaemolyticus outer membrane proteins [J].Fish Shellfish Immunol, 2013, 34(1):192-198.
[17] 刘祥, 李惠.大肠埃希菌外膜蛋白OmpA表达质粒构建和诱导条件优化[J].生物技术, 2013, 23(4):32-36.
[18] Courter D, Cao H, Kwok S, et al.The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways[J].PLoS One, 2010, 5(3):e9633.
[19] Tanabe N, Wheal B D, Kwon J, et al.Osteopontin signals through calcium and nuclear factor of activated T cells (NFAT) in osteoclasts:A novel RGD-dependent pathway promoting cell survival[J].J Biol Chem, 2011, 286(46):39871-39881.
[20] Iczkiewicz J, Broom L, Cooper J D, et al.The RGD-containing peptide fragment of osteopontin protects tyrosine hydroxylase positive cells against toxic insult in primary ventral mesencephalic cultures and in the rat substantia nigra[J]. J Neurochem, 2010, 114(6):1792-1804.
[21] 姚秀娟, 孙杰, 姚守秀, 等.实时定量PCR检测蛋壳形成时骨桥蛋白表达变化的研究[J].中国畜牧兽医, 2010, 37(4):113-118.
[22] 杨国伟, 张冬杰, 汪晓鸿, 等.不同日龄大白猪骨桥蛋白基因的表达研究[J].中国畜牧兽医, 2009, 36(3):45-48.
[23] 李彩虹, 刘钟杰, 郑世军, 等.松果菊苷对大鼠成骨细胞胃桥素基因和蛋白质的影响[J].中国畜牧兽医, 2013, 40(4):50-54.
[24] 李千军, 王立刚, 穆淑琴, 等.ESR、FSHβ及OPN基因多态性与母猪繁殖性状的关联分析[J].中国畜牧兽医, 2010, 37(10):139-143.
[25] 刘祥, 陈春琳, 牟欢, 等.重组人骨硬化蛋白的表达、纯化及多克隆抗体制备[J].生物技术, 2014, 24(6):68-72.